Evidence map›Paper›PMID 39263964›Full record

ArticleFuture medicinal chemistry2024

Synthesis, anticancer activity, docking and computational studies of new pyridyl-glycosyl hybrids and acyclic analogs.

Mohamed N El-Bayaa, Eman R Kotb, Sabri Messaoudi, Hanem M Awad, Mahmoud G Saleh, Hanan A Soliman

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Future medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mohamed N El-BayaaDepartment of Chemistry, College of Science, Qassim University, Buraidah, 51452, Saudi Arabia.ORCID 0000-0003-3896-7025
Eman R KotbPhotochemistry Department, National Research Centre, Dokki, P.O. Box 12622, Cairo, Egypt.
Sabri MessaoudiDepartment of Chemistry, College of Science, Qassim University, Buraidah, 51452, Saudi Arabia.
Hanem M AwadTanning Materials & Leather Technology Department, National Research Centre, Dokki, Giza, 12622, Egypt.
Mahmoud G SalehDepartment of Chemistry, College of Science, Northern Border University, Arar, Saudi Arabia.ORCID 0000-0001-9617-4985
Hanan A SolimanPhotochemistry Department, National Research Centre, Dokki, P.O. Box 12622, Cairo, Egypt.

Funding

The authors extend their appreciation to the Deanship of Scientific Research at Northern Border University, Arar, KSA for funding this research work through the project number NBU-FFR-2024-144-09the National Research Centre, for the Biological evaluation through project 13010101
6 · The paper itself

Abstract

New pyridine-

Indexed as

Antineoplastic AgentsCell ProliferationDrug Screening Assays, AntitumorGlycosidesMolecular Docking SimulationPyridinesCell Line, TumorCyclin-Dependent Kinase 2HumansMolecular StructureStructure-Activity RelationshipAntineoplastic AgentsCDK2 protein, humanCyclin-Dependent Kinase 2GlycosidesPyridinesacyclic nucleosidescancercell lineCytotoxicityglycosidespyridine

Identifiers

PMID39263964
PMCPMC11559364

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.